Navigation Links
Research and Markets Announces the Release of 'Autoimmune Disease Therapeutics to 2016. Targets, Technologies, Therapies, Markets and Opportunities'
Date:3/20/2013

DUBLIN, March 20, 2013 /PRNewswire/ --

Dublin - Research and Markets (http://www.researchandmarkets.com/research/t68g9q/autoimmune) has announced the addition of the "Autoimmune Disease Therapeutics to 2016. Targets, Technologies, Therapies, Markets and Opportunities" report to their offering.

     (Logo: http://photos.prnewswire.com/prnh/20130307/600769)

As a group, autoimmune diseases represent one of the most intractable families of conditions facing medical science. The complexities and genetic underpinnings of the human immune response result in a set of disease targets that are at once physiologically ubiquitous and highly individualized. Until recently, autoimmune disease patients were given little hope for an effective treatment. But the convergence of improved understanding of autoimmune disease mechanisms and the availability of recombinant cytokines has led to systemic treatments that, while not devoid of side effects, have demonstrated the ability to control autoimmune reactions in a significant number of patients. A number of potentially important pipeline drugs hold the promise of future improvements in outcomes for autoimmune disease patients.

This study analyzes current autoimmune therapeutics and assesses the next-generation of candidates and their probable impact on treatment options and the competitive landscape.

Highlights:

- Analyzes current therapeutic options for autoimmune diseases, and evaluates emerging therapeutic candidates and assesses their commercial potential

- Assesses existing and evolving immune disease mechanisms and treatment strategies

- Analyzes more than two dozen existing and emerging autoimmune disease targets and target-specific therapeutic drug products

- Evaluates regional and global opportunities for autoimmune therapeutics

- Provides market data and forecasts for six major autoimmune disease segments to 2016

Topics Covered:

Executive Summary

Autoimmune Therapeutics Segment Dynamics

Sector Market Dynamics
Patient Demographics and Growth
Chronic Disease and Self-administration
Managed Care and Prescribing Trends
Factors Limiting Growth
Industry Alignment and Competitive Landscape

Autoimmune Therapeutic Market Assessments

Arthritis
Disease Forms and Immune Mechanisms
Therapeutic Strategies
Disease Demographics and Growth
Key Approved Therapies
Development-stage Candidate Assessment
Market Factors
Commercial Outlook and Forecasts

Crohn's Disease
Disease Incidence and Demographics
Current Generation Treatment Options
Therapies in Development
Market Factors
Commercial Outlook and Forecasts

Diabetes
Restoring Islet Cell Function
Therapies in Development
Commercial Outlook and Forecasts

Lupus
The Ongoing Unmet Need
Pipeline Candidates - A Ray of Hope
Market Factors
The Potential for a Lupus-specific Therapy
Commercial Outlook and Forecasts

Multiple Sclerosis
Disease Mechanisms and Therapeutic Strategies
The Market Opportunity
Competitive Landscape
Development-stage Candidate Assessment
Market Factors
Commercial Outlook and Forecasts

Psoriasis
Therapeutic Options and Expanded Indications
Prescribing Trends and Drug Efficacy
Market Sector Factors
Development-stage Candidate Assessment
Commercial Outlook and Forecasts
Market Factors
Risk Factors
Clinical Trial Factors
Product Issues

Autoimmune Therapeutics - Company Profile

For more information visit http://www.researchandmarkets.com/research/t68g9q/autoimmune

Research and Markets
Laura Wood , Senior Manager.
press@researchandmarkets.com
U.S. Fax: +1-646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Drug Delivery


'/>"/>
SOURCE Research and Markets
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Hologics 3D Mammography Technology to be the "New Standard of Care," According to Healthcare Research Firm KLAS
2. Nanotechnology Market Research Review and Conference Opportunities
3. CVS Caremark Research Finds Medication Adherence Can Improve Outcomes and Reduce Costs for Patients with Coronary Artery Disease
4. National Pharmaceutical Council Survey Shows Health Care Stakeholders Continue to Show Optimism About the Future Role of Comparative Effectiveness Research
5. Research-based Pharmaceutical Industry and International Federation of Red Cross and Red Crescent Societies Join Forces to Prevent Non-Communicable Diseases
6. Radiofrequency Ablation Devices Market for Pain Management is Expected to Reach USD 1.0 Billion Globally in 2018: Transparency Market Research
7. Morning Research on Sequenom, Peregrine Pharma, Onyx Pharma, and Inovio Pharma
8. Researchers Expect a Marginal Increase in Laboratory Product Budgets for 2013, Finds Frost & Sullivan
9. Salix Pharmaceuticals Commits $1.125M to AGA Research Foundation
10. Positive Data, Pipeline Improvements & Market Expansion - Research Report on Abbott Laboratories, Stryker Corporation, St. Jude Medical, Cardiovascular Systems and MAKO Surgical
11. BD Announces Appointment of Dr. Ellen Strahlman as Chief Medical Officer and Senior Vice President, Research & Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2016)... April 27, 2016 Shire plc (LSE: ... Poulton , Chief Financial Officer, will present at the Deutsche ... MA on Wednesday, May 04, 2016, 10:00 am ... be available on the Presentations and Webcasts section of Shire,s ... the webcast will be available on this same website for ...
(Date:4/27/2016)... April 27, 2016 Oasmia ... developer of a new generation of drugs within ... survival results for Paclical/Apealea in the Phase III ... with epithelial ovarian cancer. These preliminary results showed ... combination with carboplatin versus Taxol in combination with ...
(Date:4/27/2016)... FRANCISCO , April 27, 2016 ... expected to reach USD 2.06 billion by 2022, ... Research, Inc. Increasing consumer awareness towards a healthy ... the next seven years.      (Logo: ... diet intake coupled with rising health treatment expenditure ...
Breaking Medicine Technology:
(Date:4/28/2016)... ... April 28, 2016 , ... Starting today, households ... mail from USA Medical Prescription Assistance Program. They are customized to reflect the ... package will include a ready-to-use, state-themed card and, in the near future, material ...
(Date:4/28/2016)... ... April 28, 2016 , ... The Aging in Motion Coalition ... an ICD-10-CM code for sarcopenia, giving it recognition for separate reporting and data collection. ... 1, 2016. , Sarcopenia is defined as a combination of low muscle mass and ...
(Date:4/28/2016)... ... April 28, 2016 , ... North Hollywood dentist , Dr. Hamid ... is essential when it comes to dental accidents or critical dental problems. These issues ... losing a tooth. Toothaches, knocked-out teeth, chipped teeth, and many other issues can lead ...
(Date:4/28/2016)... (PRWEB) , ... April 28, ... ... an invitation to those affected by a health insurance co-operative bankruptcy to ... proprietary process, individuals can receive over 1,500 FDA-approved prescription medications from over ...
(Date:4/28/2016)... , ... April 28, 2016 , ... For many, a diet is only as good ... if it does not look good. In addition, an individual cannot deny the importance of ... , The team, therefore, has worked to create a product range that could entice people ...
Breaking Medicine News(10 mins):